Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 70Triple Negative Breast Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 4Inflammatory Breast Neoplasms 3Seroma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Invasive Breast Cancer 2Carcinoma, Ductal, Breast 2Breast Cancer Invasive 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sarcoma 1Premenopausal Breast Cancer 1Patient Preference 1Pain, Postoperative 1Pain 1Neoplastic Cells, Circulating 1Neoplasms 1Myofibroma 1Mesothelioma, Malignant 1Lymphatic Metastasis 1Inflammation 1Hereditary Breast and Ovarian Cancer Syndrome 1HER2-positive Early Breast Cancer 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

Paclitaxel 3Doxorubicin 3Cyclophosphamide 3Trastuzumab 2Surgical Procedures, Operative 2Carboplatin 2pertuzumab 1liposomal doxorubicin 1cemiplimab 1atezolizumab 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Lapatinib 1Indocyanine Green 1Anastrozole 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Invasive Breast Cancer × Surgical Procedures, Operative × Breast × Clear all
NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting
650 enrolled
Breast

Invasive Breast Cancer

NCT01717131 2024-01-11

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Institut Paoli-Calmettes

Phase NA Active not recruiting
2,228 enrolled
Breast

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡